Hypoxia-inducible factor-1 in tumour angiogenesis

World J Gastroenterol. 2004 Apr 15;10(8):1082-7. doi: 10.3748/wjg.v10.i8.1082.

Abstract

Hypoxia-inducible factor-1 (HIF-1), composed of HIF-alpha and HIF-beta subunits, is a heterodimeric transcriptional activator. In response to hypoxia, stimulation of growth factors, and activation of oncogenes as well as carcinogens, HIF-1alpha is overexpressed and/or activated and targets those genes which are required for angiogenesis, metabolic adaptation to low oxygen and promotes survival. HIF-1 is critical for both physiological and pathological processes. Several dozens of putative direct HIF-1 target genes have been identified on the basis of one or more cis-acting hypoxia-response elements that contain an HIF-1 binding site. A variety of regulators including growth factors, genetic alterations, stress activators, and some carcinogens have been documented for regulation of HIF-1 in which several signaling pathways are involved depending on the stimuli and cell types. Activation of HIF-1 in combination with activated signaling pathways and regulators is implicated in tumour progression and prognosis. This review presents a summary of the structure and function of HIF-1alpha, and correlation among specific regulators and their signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Transcription Factors
  • Humans
  • Neoplasms / blood supply*
  • Neoplasms / physiopathology*
  • Neovascularization, Pathologic / physiopathology*
  • Trans-Activators / physiology*

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Trans-Activators
  • endothelial PAS domain-containing protein 1